Flying blind: The US government’s pandemic response with Dr. Tom Frieden

Flying Blind: The US Government’s Pandemic Response | Dr. Tom Frieden | GZERO World with Ian Bremmer

Former CDC director – and current CEO of the public health initiative Resolve to Save Lives – Dr. Tom Frieden joins Ian Bremmer on GZERO World to talk about how to get the Covid-19 pandemic under control in the United States (hint: we need more data). As with politics, Dr. Frieden argues, all epidemics are local. And the outbreaks crippling much of the South and Southwest need local responses. But the main failing lies at the federal level. Things won't improve (and schools won't effectively reopen) Dr. Frieden warns, until Washington alters course. That is, of course, until an effective vaccine becomes readily accessible to all Americans. Though even that will likely not be the silver bullet we all want it to be.

Partisanship, lack of data, the need to slow community spread, healthcare workers getting sick, a weak US primary care system, financial mis-incentives, globalization and the spread of pathogens - and the damage of COVID-19 that is still not fully understood - Dr. Frieden's conversation with Ian Bremmer digs deep into the state of the coronavirus response, implications for our lives today, and the medical developments to watch for next.

More from GZERO Media

Chart of the most consequential Supreme Court cases of 2025.
Eileen Zhang

The 2025 Supreme Court term began this month, ushering in a slate of cases that could reshape American governance. No one will be watching more closely than President Donald Trump, whose efforts to expand executive power and limit independent oversight will be under the judicial microscope.

Kenya's opposition leader Raila Odinga addresses delegates after President William Ruto signed the Independent Electoral and Boundaries Commission Amendment Bill 2024, backed by the National Dialogue Committee (NADCO), at the Kenyatta International Conference Centre in Nairobi, Kenya, on July 9, 2024.
REUTERS/Thomas Mukoya

When Walmart stocks its shelves with homegrown products like Fischer & Wieser’s peach jam, it’s not just selling food — it’s creating opportunity. Over two-thirds of what Walmart buys is made, grown, or assembled in America, fueling jobs and growth in communities nationwide. Walmart’s $350 billion commitment to US manufacturing is supporting 750,000 jobs and empowering small businesses to sell more, hire more, and strengthen their hometowns. From farms to shelves, Walmart’s investment keeps local businesses thriving. Learn how Walmart's commitment to US manufacturing is supporting 750K American jobs.

Earlier this month, Microsoft released the 2025 TechSpark Impact Report, which highlights how the company is assisting regions across the US in achieving these goals. Since its launch, TechSpark has obtained over $700 million in community funding, supported more than 65,000 people in developing digital skills, and, thanks to the work of TechSpark Fellows, catalyzed $249M+ in funding and upskilled 34,600 individuals across 46 communities — highlighting the ripple effect of local leadership and innovation. Learn more about this progress in the 2025 report here.

People walk past a jewelry store in the Diamond District of Manhattan, New York City, USA, on August 6, 2025.
Jimin Kim / SOPA Images via Reuters Connect

GZERO spoke to Eurasia Group’s Commodities Director Tim Puko to better understand why the diamond industry has tanked, and the consequences of this for geopolitics.

- YouTube

In Ask Ian, Ian Bremmer notes that US–China relations are once again on edge. After Washington expanded export controls on Chinese tech firms, Beijing struck back with new limits on critical minerals. President Trump responded by threatening 100% tariffs, then quickly walked them back.

In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.